Therapeutic Goods (Authorised Supply) Amendment (Medicines and Medical Devices) Rules 2022 (Cth)

Therapeutic Goods (Authorised Supply) Amendment (Medicines and Medical Devices) Rules 2022

I, Jane Cook, as delegate of the Minister for Health and Aged Care, make the following rules.

Dated 9 February 2022

Dr Jane Cook

Chief Medical Adviser

Health Products Regulation Group

Department of Health

Contents

1. •
2. •
3. •
4. •

1Name

This instrument is the Therapeutic Goods (Authorised Supply) Amendment (Medicines and Medical Devices) Rules 2022.

2Commencement

1. (1)

   Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	The day after this instrument is registered.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

1. (2)

   Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3Authority

This instrument is made under subsections 19(7A) and 41HC(6) of the Therapeutic Goods Act 1989.

4Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1AmendmentsPart 1MedicinesTherapeutic Goods (MedicinesAuthorised Supply) Rules 20201

Schedule 1 (table item 1)

Repeal the item.

2

Schedule 1 (table items 10 and 11)

Repeal the items.

3

Schedule 1 (before table item 12)

Insert:

11A ciclosporin, 0.05% eye drops, emulsion ophthalmic treatment of suppressed tear production due to ocular inflammation associated with keratoconjunctivitis sicca (dry eye syndrome)

4

Schedule 1 (after table item 16)

Insert:

16A	colecalciferol	capsule	oral	treatment of severe vitamin D deficiency and prevention of osteoporosis
16B	colecalciferol	injection	intramuscular	treatment of severe vitamin D deficiency and prevention of osteoporosis

5

Schedule 1 (table item 18)

Repeal the item.

6

Schedule 1 (after table item 26)

Insert:

26A disulfiram tablet oral deterrent to alcohol consumption

7

Schedule 1 (after table item 40)

Insert:

40A iloprost injection intravenous infusion treatment of patients with severe disabling Raynaud’s phenomenon; or treatment of peripheral ischaemia

8

Schedule 1 (after table item 42)

Insert:

42A interferon alpha-2b eye drops ophthalmic treatment of ocular surface squamous neoplasia

9

Schedule 1 (after table item 46)

Insert:

46A lifitegrast eye drops ophthalmic treatment of dry eye disease

10

Schedule 1 (after table item 62)

Insert:

62A	progesterone	injection	subcutaneous	treatment of progesterone deficiency
62B	progesterone in oil	injection	intramuscular	treatment of progesterone deficiency

11

Schedule 1 (after table item 71)

Insert:

71A Technetium-99m (99m Tc) prostate specific membrane antigen (PSMA)-I&S injection intravenous prostate cancer imaging study

Part 2Medical devicesTherapeutic Goods (Medical DevicesAuthorised Supply) Rules 202012

Schedule 1 (table item 4)

Repeal the item.

13

Schedule 1 (before table item 5)

Insert:

4A AltiVate Reverse Shoulder system – DJO Global for arthroplasty of the shoulder orthopaedic surgeon

14

Schedule 1 (table item 5, column 4)

Omit “medical practitioner”, substitute “general surgeon”.

15

Schedule 1 (table item 6, column 4)

Omit “medical practitioner”, substitute “obstetrics and gynaecology specialist”.

16

Schedule 1 (after table item 10)

Insert:

10A Duraloc Acetabular Cup System – Hip Insert/Liner – Johnson & Johnson t/a DePuy Synthes revision hip arthroplasty orthopaedic surgeon

17

Schedule 1 (table item 11, column 4)

Omit “medical practitioner”, substitute “obstetrics and gynaecology specialist”.

18

Schedule 1 (table item 12, column 4)

Omit “medical practitioner”, substitute “obstetrics and gynaecology specialist”.

19

Schedule 1 (table item 13, column 4)

Omit “medical practitioner”, substitute “obstetrics and gynaecology specialist”.

20

Schedule 1 (table item 14, column 4)

Omit “medical practitioner”, substitute “plastic surgeon”.

21

Schedule 1 (table item 15, column 4)

Omit “medical practitioner”, substitute “plastic surgeon”.

22

Schedule 1 (table item 17, column 4)

Omit “medical practitioner”, substitute “obstetrics and gynaecology specialist”.

23

Schedule 1 (table item 21, column 4)

Omit “medical practitioner”, substitute “cardiothoracic surgeon”.

24

Schedule 1 (table item 22)

Repeal the item.

25

Schedule 1 (table item 23)

Repeal the item.

26

Schedule 1 (table item 26, column 2)

Omit “Durasel”, substitute “Durasul PE”.

27

Schedule 1 (after table item 31)

Insert:

31A Primetech Piezo Micro Manipulator and microinjection pipettes in vitro fertilisation obstetrics and gynaecology specialist

28

Schedule 1 (after table item 35)

Insert:

35A Regeneten Bioinductive Implant – Bone Anchors with Anthroscopic Delivery System rotator cuff surgery orthopaedic surgeon